Leukoaraiosis predicts cortical infarct volume after distal middle cerebral artery occlusion

Stroke

Volumn 45, Issue 3, 2014, Pages 689-695

  Henninger, Nils ^a   Khan, Muhib A ^a   Zhang, Jiaying ^a   Moonis, Majaz ^a   Goddeau, Richard P ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Cerebral small vessel diseases; Lacunar; Leukoaraiosis; Stroke

Indexed keywords

ALTEPLASE; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; WARFARIN;

ADULT; AGED; ARTICLE; BRAIN CORTEX; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CLINICAL ASSESSMENT TOOL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONFIDENCE INTERVAL; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DATA BASE; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; DYSLIPIDEMIA; ENDOVASCULAR SURGERY; FEMALE; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; LABORATORY TEST; LEUKOARAIOSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MIDDLE CEREBRAL ARTERY OCCLUSION; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEUROIMAGING; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; RANKIN SCALE; RATING SCALE; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STROKE PATIENT; TRANSIENT ISCHEMIC ATTACK; VAN SWIETEN SCALE; VERY ELDERLY; WHITE MATTER; BRAIN ANGIOGRAPHY; CEREBRAL ARTERY DISEASE; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONVALESCENCE; FIBRINOLYTIC THERAPY; IMAGE PROCESSING; LACUNAR STROKE; PATHOLOGY; REGRESSION ANALYSIS; TREATMENT OUTCOME;

CEREBRAL SMALL VESSEL DISEASES; LEUKOARAIOSIS; STROKE; STROKE, LACUNAR;

AGED; AGED, 80 AND OVER; CEREBRAL ANGIOGRAPHY; ENDOVASCULAR PROCEDURES; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INFARCTION, MIDDLE CEREBRAL ARTERY; LEUKOARAIOSIS; MALE; MIDDLE AGED; NEUROIMAGING; PREDICTIVE VALUE OF TESTS; RECOVERY OF FUNCTION; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; THROMBOLYTIC THERAPY; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84899156141     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.002855     Document Type: Article

References (35)

1. Arsava EM, Rahman R, Rosand J, Lu J, Smith EE, Rost NS, et al. Severity of leukoaraiosis correlates with clinical outcome after ischemic stroke. Neurology. 2009;72:1403-1410.
2. Henninger N, Lin E, Baker SP, Wakhloo AK, Takhtani D, Moonis M. Leukoaraiosis predicts poor 90-day outcome after acute large cerebral artery occlusion. Cerebrovasc Dis. 2012;33:525-531.
3. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9:689-701.
4. Ay H, Arsava EM, Rosand J, Furie KL, Singhal AB, Schaefer PW, et al. Severity of leukoaraiosis and susceptibility to infarct growth in acute stroke. Stroke. 2008;39:1409-1413.
5. Henninger N, Lin E, Haussen DC, Lehman LL, Takhtani D, Selim M, et al. Leukoaraiosis and sex predict the hyperacute ischemic core volume. Stroke. 2013;44:61-67.
6. Yoo AJ, Chaudhry ZA, Nogueira RG, Lev MH, Schaefer PW, Schwamm LH, et al. Infarct volume is a pivotal biomarker after intra- Arterial stroke therapy. Stroke. 2012;43:1323-1330.
7. Zaidi SF, Aghaebrahim A, Urra X, Jumaa MA, Jankowitz B, Hammer M, et al. Final infarct volume is a stronger predictor of outcome than recanalization in patients with proximal middle cerebral artery occlusion treated with endovascular therapy. Stroke. 2012;43:3238-3244.
8. Vora NA, Shook SJ, Schumacher HC, Tievsky AL, Albers GW, Wechsler LR, et al. A 5-item scale to predict stroke outcome after cortical middle cerebral artery territory infarction: validation from results of the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) Study. Stroke. 2011;42:645-649.
9. Schiemanck SK, Kwakkel G, Post MW, Prevo AJ. Predictive value of ischemic lesion volume assessed with magnetic resonance imaging for neurological deficits and functional outcome poststroke: A critical review of the literature. Neurorehabil Neural Repair. 2006;20:492-502.
10. O'Sullivan M, Lythgoe DJ, Pereira AC, Summers PE, Jarosz JM, Williams SC, et al. Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis. Neurology. 2002;59:321-326.
11. Held V, Szabo K, Bazner H, Hennerici MG. Chronic small vessel disease affects clinical outcome in patients with acute striatocapsular stroke. Cerebrovasc Dis. 2012;33:86-91.
12. Brown WR, Moody DM, Thore CR, Challa VR, Anstrom JA. Vascular dementia in leukoaraiosis may be a consequence of capillary loss not only in the lesions, but in normal- Appearing white matter and cortex as well. J Neurol Sci. 2007;257:62-66.
13. Oishi M, Mochizuki Y, Hara M, Takasu T. Central motor conduction time in patients with periventricular lucencies. J Neurol Sci. 1996;142:30-35.
14. Cauley KA, Thangasamy S, Dundamadappa SK. Improved image quality and detection of small cerebral infarctions with diffusion- Tensor trace imaging. AJR Am J Roentgenol. 2013;200:1327-1333.
15. Lima FO, Furie KL, Silva GS, Lev MH, Camargo EC, Singhal AB, et al. The pattern of leptomeningeal collaterals on CT angiography is a strong predictor of long- Term functional outcome in stroke patients with large vessel intracranial occlusion. Stroke. 2010;41:2316-2322.
16. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al; STandards for Reporting Vascular changes on nEuroimaging (STRIVE vl). Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12:822-838.
17. van Swieten JC, Hijdra A, Koudstaal PJ, van Gijn J. Grading white matter lesions on CT and MRI: A simple scale. J Neurol Neurosurg Psychiatry. 1990;53:1080-1083.
18. Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3:32-35.
19. Simoni M, Li L, Paul NL, Gruter BE, Schulz UG, Kiiker W, et al. Age- And sex-specific rates of leukoaraiosis in TIA and stroke patients: population-based study. Neurology. 2012;79:1215-1222.
20. Inzitari D, Pracucci G, Poggesi A, Carlucci G, Barkhof F, Chabriat H, et al; LADIS Study Group. Changes in white matter as determinant of global functional decline in older independent outpatients: Three year follow-up of LADIS (leukoaraiosis and disability) study cohort. BMJ. 2009;339:b2477.
21. Vermeer SE, Hollander M, van Dijk EJ, Hofman A, Koudstaal PJ, Breteler MM; Rotterdam Scan Study. Silent brain infarcts and white matter lesions increase stroke risk in the general population: The Rotterdam Scan Study. Stroke. 2003;34:1126-1129.
22. Meisel C, Schwab JM, Prass K, Meisel A, Dimagl U. Central nervous system injury-induced immune deficiency syndrome. Nat Rev Neurosci. 2005;6:775-786.
23. Singer OC, Humpich MC, Fiehler J, Albers GW, Lansberg MG, Kastrup A, et al; MR Stroke Study Group Investigators. Risk for symptomatic intracerebral hemorrhage after thrombolysis assessed by diffusion- weighted magnetic resonance imaging. Ann Neurol. 2008;63:52-60.
24. Rangaraju S, Owada K, Noorian AR, Nogueira RG, Nahab F, Glenn BA, et al. Comparison of final infarct volumes in patients who received endovascular therapy or intravenous thrombolysis for acute intracranial large-vessel occlusions. JAMA Neurol. 2013;70:831-836.
25. Sonnen JA, Larson EB, Crane PK, Haneuse S, Li G, Schellenberg GD, et al. Pathological correlates of dementia in a longitudinal, population- based sample of aging. Ann Neurol. 2007;62:406-413.
26. Gold G, Giannakopoulos P, Herrmann FR, Bouras C, Kovari E. Identification of Alzheimer and vascular lesion thresholds for mixed dementia. Brain. 2007;130(pt 11):2830-2836.
27. Tomimoto H, Akiguchi I, Wakita H, Osaki A, Hayashi M, Yamamoto Y. Coagulation activation in patients with Binswanger disease. Arch Neurol. 1999;56:1104-1108.
28. Iwamoto T, Kubo H, Takasaki M. Platelet activation in the cerebral circulation in different subtypes of ischemic stroke and Binswanger's disease. Stroke. 1995;26:52-56.
29. Markus HS. Genes, endothelial function and cerebral small vessel disease in man. Exp Physiol. 2008;93:121-127.
30. Grips E, Sedlaczek O, Bazner H, Fritzinger M, Daffertshofer M, Hennerici M. Supratentorial age-related white matter changes predict outcome in cerebellar stroke. Stroke. 2005;36:1988-1993.
31. Ihara M, Tomimoto H, Ishizu K, Mukai T, Yoshida H, Sawamoto N, et al. Decrease in cortical benzodiazepine receptors in symptomatic patients with leukoaraiosis: A positron emission tomography study. Stroke. 2004;35:942-947.
32. Akiguchi I, Tomimoto H, Suenaga T, Wakita H, Budka H. Alterations in glia and axons in the brains of Binswanger's disease patients. Stroke. 1997;28:1423-1429.
33. O'Sullivan M. Imaging small vessel disease: Lesion topography, networks, and cognitive deficits investigated with MRI. Stroke. 2010;41 (10 suppl):S154-S158.
34. O'Sullivan M, Morris RG, Huckstep B, Jones DK, Williams SC, Markus HS. Diffusion tensor MRI correlates with executive dysfunction in patients with ischaemic leukoaraiosis. J Neurol Neurosurg Psychiatry. 2004;75:441-447.
35. Ryberg C, Rostrup E, Sjdstrand K, Paulson OB, Barkhof F, Scheltens P, et al; LADIS Study Group. White matter changes contribute to corpus callosum atrophy in the elderly: The LADIS study. AJNR Am J Neuroradiol. 2008;29:1498-1504.